Harvard University has received a $50 million gift from businessman and alumnus Len Blavatnik to support a major initiative aimed at bridging the “valley of death” — the gap between basic biomedical research and the emergence of new therapies for patients. Greg Verdine, the Erving Professor of Chemistry in the Department of Stem Cell and Regenerative Biology and of Chemistry and Chemical Biology at FAS, is quoted.
